Cetera Investment Advisers Takes $204,000 Position in Phibro Animal Health Co. (NASDAQ:PAHC)

Cetera Investment Advisers purchased a new stake in Phibro Animal Health Co. (NASDAQ:PAHC) during the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund purchased 9,710 shares of the company’s stock, valued at approximately $204,000.

A number of other institutional investors also recently modified their holdings of PAHC. Aquatic Capital Management LLC bought a new stake in shares of Phibro Animal Health in the fourth quarter valued at about $69,000. Quantbot Technologies LP lifted its holdings in shares of Phibro Animal Health by 65.1% in the fourth quarter. Quantbot Technologies LP now owns 5,116 shares of the company’s stock valued at $107,000 after purchasing an additional 2,018 shares in the last quarter. Meeder Asset Management Inc. bought a new stake in shares of Phibro Animal Health in the fourth quarter valued at about $113,000. New York State Teachers Retirement System lifted its holdings in shares of Phibro Animal Health by 16.7% in the fourth quarter. New York State Teachers Retirement System now owns 5,428 shares of the company’s stock valued at $114,000 after purchasing an additional 775 shares in the last quarter. Finally, Nebula Research & Development LLC bought a new stake in shares of Phibro Animal Health in the fourth quarter valued at about $210,000. 99.34% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

Several analysts recently issued reports on the company. Wall Street Zen upgraded Phibro Animal Health from a “hold” rating to a “buy” rating in a report on Friday, May 9th. Morgan Stanley upped their target price on Phibro Animal Health from $20.00 to $21.00 and gave the stock an “equal weight” rating in a report on Thursday, May 8th. Finally, Barclays upped their target price on Phibro Animal Health from $20.00 to $22.00 and gave the stock an “underweight” rating in a report on Monday, February 10th. Two research analysts have rated the stock with a sell rating, two have assigned a hold rating and one has issued a buy rating to the stock. Based on data from MarketBeat, Phibro Animal Health currently has an average rating of “Hold” and a consensus target price of $20.00.

Phibro Animal Health Price Performance

Shares of NASDAQ PAHC opened at $24.58 on Monday. The business’s 50 day moving average price is $20.52 and its two-hundred day moving average price is $21.85. The company has a market cap of $996.33 million, a PE ratio of 51.21, a price-to-earnings-growth ratio of 0.45 and a beta of 0.62. The company has a quick ratio of 1.37, a current ratio of 3.20 and a debt-to-equity ratio of 2.99. Phibro Animal Health Co. has a twelve month low of $16.16 and a twelve month high of $26.55.

Phibro Animal Health (NASDAQ:PAHC) last announced its quarterly earnings results on Wednesday, May 7th. The company reported $0.63 earnings per share for the quarter, topping analysts’ consensus estimates of $0.52 by $0.11. The firm had revenue of $347.80 million for the quarter, compared to the consensus estimate of $352.41 million. Phibro Animal Health had a return on equity of 25.35% and a net margin of 1.75%. On average, analysts predict that Phibro Animal Health Co. will post 1.95 EPS for the current year.

Phibro Animal Health Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, June 25th. Shareholders of record on Wednesday, June 4th will be given a dividend of $0.12 per share. This represents a $0.48 dividend on an annualized basis and a yield of 1.95%. The ex-dividend date of this dividend is Wednesday, June 4th. Phibro Animal Health’s dividend payout ratio (DPR) is presently 61.54%.

Phibro Animal Health Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.